LakeShore Biopharma Co., Ltd Ordinary Shares share price logo

LakeShore Biopharma Co., Ltd Ordinary Shares

OTC: LSBCF

$0.07

Live

as on

LakeShore Biopharma Co., Ltd Ordinary Shares Stock Performance

as on June 16, 2026 at 3:36 am IST

  • $0.07
    $0.07
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

LakeShore Biopharma Co., Ltd Ordinary Shares share price movements today

Previous Close
$0.07
Open
$0.07
Volume
24.8K
Market Cap
$2.8M
Day's Low - High
$0.07 - $0.07

LakeShore Biopharma Co., Ltd Ordinary Shares Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

LakeShore Biopharma Co., Ltd Ordinary Shares Stock Fundamentals & Key Indicators

Check LakeShore Biopharma Co., Ltd Ordinary Shares market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.8M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.00

Return On Equity TTM

-18.43%

LakeShore Biopharma Co., Ltd Ordinary Shares stock Key Stats

Compare market cap, revenue, PE, and other key metrics of LakeShore Biopharma Co., Ltd Ordinary Shares with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$2.8MNANA-16.26%0.00%

LakeShore Biopharma Co., Ltd Ordinary Shares Quarterly Profit & Loss

All numbers in Millions USD

Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Jun 2024
Total Revenue
116
116
205
194
180
106
176
96
168
135
Gross Profit
90
90
154
152
142
84
141
79
133
34
Operating Income
-1
-1
-2
-5
-47
-73
-70
-113
-81
-181
EBITDA
-1
-1
-2
114
-40
-55
-60
-98
-72
-82
Interest Expense
-
-
49
54
-
-
8
6
8
23
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
19
45
11
-29
-87
-111
-70
-105
-84
-194
Income Tax Expense
0
0
0
0
1
0
0
0
-7
-13
Net Income
19
45
11
8
-52
-111
-69
-104
-77
-181
Net Profit Margin
16.90%
38.77%
5.61%
4.36%
-29.22%
-104.67%
-39.45%
-108.43%
-46.10%
-133.86%

LakeShore Biopharma Co., Ltd Ordinary Shares Annual Profit & Loss

All numbers in Millions USD

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
257
79
99
79
84
Gross Profit
197
60
77
63
69
Operating Income
-125
-118
-139
-445
-86
EBITDA
-116
-67
-76
-368
-48
Interest Expense
29
2
30
44
15
Depreciation
-
31
36
42
36
Income Before Tax
-190
-231
-282
-455
-100
Income Tax Expense
17
4
1
-21
0
Net Income
-191
-37
-21
-60
-13
Net Profit Margin
-74.64%
-47.06%
-21.17%
-75.59%
-16.26%

LakeShore Biopharma Co., Ltd Ordinary Shares Quarterly Cash Flow

All numbers in Millions USD

Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Jun 2024
Net Income
45
11
-29
-88
-111
-69
-105
-77
-181
Operating Cash Flow
-1
0
-
-
-
-
-
-
-
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
-
-
-
-
-
-
-
-
Change in Cash
-1
0
-
-
-
-
-
-
-

LakeShore Biopharma Co., Ltd Ordinary Shares Annual Cash Flow

All numbers in Millions USD

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Income
-106
-145
-433
-99
Operating Cash Flow
-173
-182
-295
-120
Investing Cash Flow
-298
-56
-44
-17
Financing Cash Flow
364
317
205
-3
Change in Cash
-119
99
-123
-139

About LakeShore Biopharma Co., Ltd Ordinary Shares

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer. Its product pipeline includes YSJA, a conventional rabies vaccine, which is in marketed stage; PIKA, a rabies vaccine, which is in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic candidate that is in phase I trial for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine, which is in phase I trial; PIKA YS-HBV-002, an immune-therapy vaccine that is in preclinical trial for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine, which are in preclinical trials. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 1994 and is based in Beijing, China.
OrganisationLakeShore Biopharma Co., Ltd Ordinary Shares
HeadquartersBuilding No. 2, Beijing, China, 102629
IndustryBiotechnology
CEOMr. Wang Xu

Key Management of LakeShore Biopharma Co., Ltd Ordinary Shares

Name

Title

Mr. Wang Xu

CEO & Director

Ms. Rui Yu M.B.A., M.S.

CFO & Director

Dr. Hui Shao C.F.A., M.B.A., Ph.D.

President, Chief Business Officer & Vice Chairman

Ms. Zhiyuan Ran

Head of Marketing and Sales

Dr. Yuan Liu Ph.D.

Head of Vaccine Research

Dr. Honggang Teng

Head of Production & Quality Management

FAQs

What is LakeShore Biopharma Co., Ltd Ordinary Shares share price today?

LakeShore Biopharma Co., Ltd Ordinary Shares share price today is $0.07 as on . LakeShore Biopharma Co., Ltd Ordinary Shares share today touched a day high of $0.07 and a low of $0.07.

What is the 52 week high and 52 week low for LakeShore Biopharma Co., Ltd Ordinary Shares share?

LakeShore Biopharma Co., Ltd Ordinary Shares share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . LakeShore Biopharma Co., Ltd Ordinary Shares stock price today i.e. is trending at $0.07,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is LakeShore Biopharma Co., Ltd Ordinary Shares's market capitalisation today?

LakeShore Biopharma Co., Ltd Ordinary Shares market capitalisation is $0.00T as on .

How to invest in LakeShore Biopharma Co., Ltd Ordinary Shares Stock (LSBCF) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for LakeShore Biopharma Co., Ltd Ordinary Shares on INDmoney app. Click on Buy button.

What is the minimum amount required to buy LakeShore Biopharma Co., Ltd Ordinary Shares Stock (LSBCF) from India?

Indian investors can start investing in LakeShore Biopharma Co., Ltd Ordinary Shares (LSBCF) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in LakeShore Biopharma Co., Ltd Ordinary Shares stock (as per the Rupee-Dollar exchange rate as on ). Based on LakeShore Biopharma Co., Ltd Ordinary Shares share’s latest price of $0.07 as on June 15, 2026 at 10:06 pm IST, you will get 142.8571 shares of LakeShore Biopharma Co., Ltd Ordinary Shares. Learn more about fractional shares .